Dr Reddys Laboratories (RDY) Cash & Equivalents (2009 - 2026)
Dr Reddys Laboratories' Cash & Equivalents came in at $118.35 million for the quarter ended Jun 30, 2026, up 12.5% from $105.21 million a year earlier but down 29.6% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Cash & Equivalents (2009 - 2026) Analysis & Trends
As of Mar 31, 2026, Dr Reddys Laboratories' Cash & Equivalents was $164 million, down 4.7% from the prior year.
- Cash & Equivalents carries a five-year compound annual growth rate of -4.2% (years ended Mar 2021 to Mar 2026).
- Going back by year, Cash & Equivalents was $172 million in the year ended Mar 31, 2025 (+102.4%), $85 million in the year ended Mar 31, 2024 (+21.4%), $70 million in the year ended Mar 31, 2023 (-64.3%) and $196 million in the year ended Mar 31, 2022 (-3.4%).
- The five-year range for quarterly Cash & Equivalents is $58.9 million (the quarter ended Jun 30, 2024) to $293.3 million (the quarter ended Dec 31, 2021).
- Year-over-year, Cash & Equivalents increased in five of the last eight quarters, with growth averaging 38.3%.
- The fastest year-over-year change in Cash & Equivalents over five years came in the quarter ended Mar 31, 2022 (growth of 632.5%), and the weakest in the quarter ended Dec 31, 2022 (a decline of 74.0%).
- Business Quant data shows RDY's Cash & Equivalents at $168.11 million (quarter ended Mar 31, 2026), $209.51 million (quarter ended Dec 31, 2025) and $113.57 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Dr Reddys Laboratories | 10.22 Bn | 9.40 Bn | 396.53 Mn | 118.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 118.35 Mn |
| Mar 31, 2026 | 168.11 Mn |
| Dec 31, 2025 | 209.51 Mn |
| Sep 30, 2025 | 113.57 Mn |
| Jun 30, 2025 | 105.21 Mn |
| Mar 31, 2025 | 169.22 Mn |
| Dec 31, 2024 | 154.35 Mn |
| Sep 30, 2024 | 135.27 Mn |
| Jun 30, 2024 | 58.90 Mn |
| Mar 31, 2024 | 69.59 Mn |
| Dec 31, 2023 | 90.49 Mn |
| Sep 30, 2023 | 163.78 Mn |
| Jun 30, 2023 | 87.98 Mn |
| Mar 31, 2023 | 180.67 Mn |
| Dec 31, 2022 | 76.23 Mn |
| Sep 30, 2022 | 114.09 Mn |
| Jun 30, 2022 | 81.66 Mn |
| Mar 31, 2022 | 197.09 Mn |
| Dec 31, 2021 | 293.30 Mn |
| Sep 30, 2021 | 134.69 Mn |
API Access
Dr Reddys Laboratories Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();